VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1647970
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: severe back pain; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support. A contactable consumer reported for a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for an Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The caller was calling on behalf of her neighbour. She said her neighbour was supposed to get the second dose of Vaccine today but was not able to get it because her neighbour was experiencing severe back pain. The outcome of the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647971
Sex: F
Age:
State: MO

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: felt very dizzy; severe headache for 2-3 days; lips turned blue but returned to normal color an hour later; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 23-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration, administered in Arm Left on 26Jan2021 11:15 (at the age of 23-year-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date in 2021, the patient experienced felt very dizzy, severe headache for 2-3 days, lips turned blue but returned to normal color an hour later. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment received as a result of events. The outcome of the events felt very dizzy, severe headache for 2-3 days were recovering, lips turned blue but returned to normal color an hour later was recovered on an unspecified date in 2021. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647972
Sex: U
Age:
State:

Vax Date: 01/24/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: sort of a rash on my toes its like that COVID, it almost like kill veins; sort of a rash on my toes its like that COVID, it almost like kill veins; It' painful; This is a spontaneous report from a non-contactable other healthcare professional. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 24Jan2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included vasculitis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced sort of a rash on the toes its like that covid, it almost like kill veins its painful on an unspecified date with outcome of unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1647973
Sex: F
Age:
State: IN

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Lymph node issues (upper right clavicle area). Painful and swollen.; Feverish; extreme fatigue; Lymph node issues (upper right clavicle area). Painful and swollen.; This is a spontaneous report from a contactable other health care professional (patient). A 63-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EJ1683) via intramuscularly on 08Jan2021 08:15 AM (at the age of 63-year-old) on right arm as a dose 2, single for COVID-19 immunization. Patient previously received first dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE), as a dose 1, single for COVID-19 immunization. The patient medical history included hyperlipidemia. Patient was allergic to Sulfa Drugs, Cephalexin, Statins. The concomitant medication in two weeks included levothyroxine sodium (SYNTHROID), escitalopram oxalate (LEXAPRO), vitamin B complex (VITAMIN B), vitamin C ascorbic acid (VITAMIN C ASCORBIC ACID), and vitamin D3 (VITAMIN D3). The patient did not receive any other vaccines within four weeks. patient was not tested to covid post vaccination and doesnt had COVID prior vaccination. On 09Jan2021 10:30 AM, patient experienced Lymph node issues (upper right clavicle area). Painful and swollen. Feverish and extreme fatigue. Patient had not received any treatment for the events. Patient was visited to doctor or other healthcare professional office/clinic. Outcome of events was recovering. Follow-up attempts completed. No further information expected.

Other Meds: SYNTHROID; LEXAPRO; VITAMIN B; VITAMIN C [ASCORBIC ACID]; VITAMIN D3

Current Illness:

ID: 1647974
Sex: M
Age:
State: MA

Vax Date: 02/10/2021
Onset Date: 02/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210215; Test Name: Fever; Result Unstructured Data: Test Result:102

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Intense chills; high fever of 102; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9262) via an unspecified route of administration in Arm Right on 10Feb2021 10:15 (at the age of 75 years old) as dose 1, single for COVID-19 immunisation at workplace clinic. Medical history included diabetes, high blood pressure, cholesterol, quadruple bypass, defibrillator, 1 eye, allergies to statin medication. Concomitant medication(s) included clopidogrel (CLOPIDOGREL), captopril (CAPTOPRIL), glipizide (GLIPIZIDE), metformin (METFORMIN), all taken for an unspecified indication, start and stop date were not reported. Patient did not received other vaccine in four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. On 15Feb2021 02:00 the patient experienced intense chills, high fever of 102, which lasted for 6 hours. Disappeared after taking 2 extra strength tylenol. Patient did not tested for COVID post vaccination. The patient underwent lab tests and procedures which included body temperature: 102 on 15Feb2021. Therapeutic measures were taken as a result of intense chills, high fever of 102. Outcome of all the events were recovered on 15Feb2021 08:00. Follow-up attempts completed. No further information expected.

Other Meds: CLOPIDOGREL; CAPTOPRIL; GLIPIZIDE; METFORMIN

Current Illness:

ID: 1647975
Sex: F
Age:
State: AK

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: 3rd day my joints, neck and back hurt for the next 3 days; 3rd day my joints, neck and back hurt for the next 3 days; 3rd day my joints, neck and back hurt for the next 3 days; feeling like I was going to get fever; cheeks and ears turned red and hot; This is a spontaneous report from a contactable consumer (patient, self-reported). A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3249 and expiry date was not reported), via an unspecified route of administration, in Arm Right, on 28Jan2021 at 12:00 PM (age at vaccination: 45 years), as a single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included Hashimoto's, lichen planopilaris, stroke, brain aneurysm, degenerate disc disease, and adhesive, dust, mold, mildew allergy. The past drug included Morphine and Darvocet which had allergies. Concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on first night she started feeling like she was going to get a fever, cheeks and ears turned red and hot. Took temp but not out of ordinary. Second night she was fine. On 3rd day her joints, neck and back hurt for the next 3 days on 28Jan2021 at 06:00 PM. The patient did not receive any treatment for the events. The outcome of the events was recovered with lasting effects or sequel on an unspecified date. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647976
Sex: F
Age:
State: CA

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:102.3 degree

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: chills; body aches; 102.3 degree fever; headache; This is a spontaneous report from a contactable other healthcare professional. A 27-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 15Feb2021 11:00 (Batch/Lot Number: EN6201) (at the age of 27-years-old) as DOSE 2, SINGLE for covid-19 immunization. Medical history included generalised anxiety disorder. There were no known allergies reported. Concomitant medications included dicyclomine, fish oil, iron and acetylcysteine (NAC 500). All taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 21Jan2021 10:00 (Batch/Lot Number: EL8982) for covid-19 immunization. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. The patient did not have covid prior to vaccination and was not tested for covid since vaccination. On 16Feb2021 12:30, the patient experienced headache, chills, body aches and 102.3 degree fever. It was reported that exactly 13 and a half hours after receiving second vaccine, the patient developed sever chills and at about 15 hours she developed significant body aches and a 102.3 degree fever. The fever continued for the remainder of the day and fell below 100 only twice. 48 hours after the second vaccine the ppatient still have a severe headache. However, the body aches and headache seem to have subsided. Laboratory tests included body temperature: 102.3 degree. The clinical outcome of the events was recovering. Follow-up attempts completed. No further information expected.

Other Meds: DICYCLOMINE; FISH OIL; IRON; NAC 500

Current Illness:

ID: 1647977
Sex: M
Age:
State: IL

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: At first feeling "hot" inside and then at night total body ache(joint/muscle); feeling "hot" inside; This is a spontaneous report from a non-contactable consumer or other non healthcare professional. A 47 year old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 13Feb2021 10:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced at first feeling "hot" inside and then at night total body ache joint or muscle on 13Feb2021 23:00 with outcome of recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1647978
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: loss of taste; This is a spontaneous report from a non-contactable consumer via medical information team. A patient of unspecified gender and age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. Reporter mentioned that his "significant other" received the Pfizer-BioNTech COVID-19 Vaccine first dose but s/he is currently experiencing some side effects (loss of taste) on an unspecified date. Outcome of the event was unknown. No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1647979
Sex: M
Age:
State: NC

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Swollen Lympnodes left arm; aches; chills; fatigue; bruising soreness swollen at injection site; bruising soreness swollen at injection site; bruising soreness swollen at injection site; fever; This is a spontaneous report from a contactable consumer. A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Arm Left on 10Feb2021 at 07:45 (at the age of 53 year) as dose 2, single for COVID-19 immunisation at Workplace clinic. Medical history included High Blood Pressure, Hypothyroidism and High Cholesterol. Patient had no known allergies. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Concomitant medication(s) included amlodipine besilate (NORVASC); simvastatine (SIMVASTATINE); levothyroxine sodium (SYNTHROID); furosemide (FUROSEMIDE). The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247), dose 1 via an unspecified route of administration in Left arm on 19Jan2021 at 08:00 AM for COVID-19 immunisation. On 10Feb2021 at 12:00 PM, patient experienced swollen lympnodes left arm, aches, chills, fatigue, bruising soreness swollen at injection site, fever all of the above lasted for 3 days, patient swollen lympnodes under left arm have just started to go down on Tuesday and patient have started being able to use my arm more with each day. It was reported that no therapeutic measures were taken for the events experienced. The outcome of events was recovered on an unknown date in Feb2021. Follow-up attempts are completed. No further information is expected.

Other Meds: NORVASC; SIMVASTATINE; SYNTHROID; FUROSEMIDE

Current Illness:

ID: 1647980
Sex: F
Age:
State: MN

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Arm pain; This is a spontaneous report from a contactable consumer or other non-HCP (patient mother) via Sponsored Program Support. A female patient of an unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as dose number unknown single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Mother wanted to know if it was okay for her not to have any side effects since everyone she knows including her daughter experienced arm pain. The outcome of the event was unknown. Information about lot/batch number has been requested. Follow-up (11May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647981
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: an allergic reaction; rashes; fever; swelling; This is a spontaneous report from a non-contactable consumer via Medical Information team. A male patient (reporter's brother) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) dose 1 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Reporter stated that her brother had symptoms of an allergic reaction after receiving the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine. She said he had rashes, fever, and swelling on an unspecified date. The outcome of events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1647982
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: sore arm; due to pain was unable to sleep; migraine for 24 hours; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration on an unspecified date for COVID-19 immunisation and was fine after the first injection. On an unspecified date, the patient experienced migraine for 24 hours, sore arm and due to pain was unable to sleep. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1647983
Sex: F
Age:
State: CA

Vax Date: 02/08/2021
Onset Date: 02/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: injection site pain; Fatigue; nausea; Dizziness; fever; chills; shaky hands; general feeling of being unwell; This is a spontaneous report from a contactable other health care professional (reported for herself). A 33-years-old female non-pregnant patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201/Batch number was not reported), dose 2 via an unspecified route of administration, administered in arm left on 08Feb2021 at 13:30 (at the age of 33-years-old) as dose 2, single for covid-19 immunisation at Public Health Clinic/ Administration facility. Medical history included attention deficit hyperactivity disorder from an unknown date and unknown if ongoing and pneumonia from an unknown date and unknown if ongoing. Concomitant medication(s) included vyvanse (LISDEXAMFETAMINE MESILATE) taken for an unspecified indication, start and stop date were not reported, trazodone (TRAZODONE) taken for an unspecified indication, start and stop date were not reported and Daily multivitamin. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL2348/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 18Jan2021 at 15:00 (at the age of 33-years-old) as dose 1, single for covid-19 immunisation and experienced vaccination site pain at Public Health Clinic/Veterans Administration facility. The patient experienced injection site pain on 08Feb2021, fatigue, nausea, dizziness, fever, chills, shaky hands and general feeling of being unwell on an unspecified date in Feb2021. Therapeutic measures were taken as a result of events fatigue, fever and chills included treatment with OTC acetaminophen. No treatment was given for the other events. The outcome of the events was not resolved. Follow-up attempts completed. No further information expected.

Other Meds: VYVANSE; TRAZODONE

Current Illness:

ID: 1647984
Sex: F
Age:
State: CA

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210209; Test Name: Temperature; Result Unstructured Data: Test Result:ranging from 99.2-101.8

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Difficulty with ADLs; Temps: ranging from 99.2-101.8; Lymph nodes swollen; Achy joints and muscles; Achy joints and muscles; Exhaustion; Abdominal Pain; Headache; Chills; blurred vision; This is a spontaneous report from a contactable nurse (Patient). A 60-year-old non-pregnant female received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was EL9266) via an unspecified route of administration, in left arm on 09Feb2021 (age at the time of vaccination was 60-year-old) as a single dose for COVID-19 immunization. Medical history included HTN (Hypertension). The patient had sulfa allergies. Concomitant medications included coreg (CARVEDILOL), advil (IBUPROFEN), tylenol (PARACETAMOL) and ASA. Previously the patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was E189982) via intramuscular route of administration in left arm on 19Jan2021 (age at the time of vaccination was 60-year-old) as a single dose for COVID-19 immunization. The patient did not have any other vaccine in four weeks. The patient did not have COVID prior to vaccination and was not tested for COVID post vaccination. On 09Feb2021, at 21:30, the patient experienced Temps: ranging from 99.2-101.8, Lymph nodes swollen, Achy joints and muscles, Exhaustion, Abdominal Pain, Headache, chills, blurred vision and Difficulty with ADLs. The patient did not receive any treatment for adverse events. Patient underwent lab test and procedure which included Body temperature ranging from 99.2-101.8 on 09Feb2021. Outcome of all the events was not recovered. Information on the lot/batch number has been requested. Follow-up (12May2021): Follow-up attempts completed. No further information expected

Other Meds: COREG; ADVIL [IBUPROFEN]; TYLENOL; ASA

Current Illness:

ID: 1647985
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: having been taking an antibiotic for a week now because of her UTI; This is a spontaneous report from a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient experienced having been taking an antibiotic for a week now because of her uti (urinary tract infection) (non-serious) on an unspecified date. Caller was asking about her mom that is scheduled today for her 2nd dose, having been taking an antibiotic for a week now because of her UTI. Therapeutic measures were taken as a result of event includes antibiotic. The outcome for event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647986
Sex: U
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Sick; This is a spontaneous report from a Pfizer sponsored program COVAX US Support. This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has missed the window for the second dose of covid-19 vaccine due to being sick. Caller is asking when it would be safe for the patient to get it. Outcome of the event was unknown. Information about lot/batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647987
Sex: F
Age:
State: NC

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Arm pain at injection site; This is a spontaneous report received from a contactable pharmacist. A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EK5730), Solution for injection, intramuscular, administered in Arm Right on 21Dec2020 (at the age of 43-year-old) as single dose for covid-19 immunisation. The patient medical history including any illness at time of vaccination was reported as none. Concomitant medications included ergocalciferol (VIT D [ERGOCALCIFEROL]) at 1000 units PO (oral) daily taken for supplementation therapy, docusate sodium (COLACE) at 100 mg PO (oral) daily taken as stool softener, loratadine (CLARITIN [LORATADINE]) at 10 mg PO (oral) daily PRN (as needed) taken for seasonal allergy, fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) at 50 mcg/ spray + spray daily PRN (as needed) each nostril taken for seasonal allergy. On 21Dec2021, the patient experienced arm pain at injection site. Patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EK9231), Solution for injection, intramuscular, administered in Arm Right on 11Jan2021 at 13:00 as 0.3 ml, single dose for covid-19 immunisation. The outcome of event was unknown. Follow-up attempts completed. No further information expected.

Other Meds: VIT D [ERGOCALCIFEROL]; COLACE; CLARITIN [LORATADINE]; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1647988
Sex: F
Age:
State: NM

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: left sided facial numbness in cheek, lip and tongue; left sided facial numbness in cheek, lip and tongue; This is a spontaneous report from a contactable other health care professional (Patient). A 45-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6201, Expiration date not reported) via intramuscular route of administration in left arm on 17Feb2021 at 10:00 (at the age of 45-year-old) as single dose for COVID-19 immunization at School or Student Health Clinic. The patient medical history was reported as none. The concomitant medications were not reported. The patient previously took erythromycin and experienced allergies on an unspecified date. The patient has not received any other vaccine in four weeks. No other medications in two weeks were reported. No COVID prior vaccination was reported. The patient has not been tested for COVID, post vaccination. On 17Feb2021 at 10:45, the patient experienced left sided facial numbness in cheek, lip and tongue; started 45 minutes after vaccine. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events. The clinical outcome of both events was not resolved. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647989
Sex: F
Age:
State: KY

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210128; Test Name: fever; Result Unstructured Data: Test Result:103; Comments: for 2.5 days

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: fever of 103 for 2.5 days; migraine; worst bone pain I have ever had; My skin hurt to go though; lymph nodes in armpit are still very swollen; This is a spontaneous report from a non-contactable other hcp (patient). A 42-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9269) via an unspecified route of administration, administered in right arm on 28Jan2021 at 14:30 (at the age of 42-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included Hashimoto's, covid prior vaccination. Patient had known allergies to antihistamine and narcotics. The concomitant medications were not reported. The patient previously received first dose of (BNT162B2, Solution for injection, Lot Number: EK9231) via an unspecified route of administration, administered in left arm on 05Jan2021 at 12:30 for covid-19 immunisation. No other vaccine in four weeks. No other medications in two weeks. No covid tested post vaccination. On 28Jan2021 at 19:00, the patient experienced fever of 103 for 2.5 days and reported a migraine (never had one before), and the worst bone pain she ever had. The patient reported my skin hurt to go though, and 2 weeks later lymph nodes in armpit were still very swollen. The patient underwent lab tests included fever 103 on 28Jan2021 (for 2.5 days). Patient did not receive any treatment. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1647990
Sex: F
Age:
State: MI

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Temperature; Result Unstructured Data: Test Result:100.2; Comments: Temperature rose to 100.2

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: With second covid vaccination, temperature rose to 100.2; This is a spontaneous report from a contactable physician. A 74-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 04Feb2021 12:05 (at the age of 74-year-old) at dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EL3248, expiration date: Exp Apr2021) via intramuscular route of administration, administered in arm right on 14Jan2021 12:05 (at the age of 74-year-old) at dose 1, single for covid-19 immunisation for which patient experienced temp increase 102.0 on 14Jan2021 17:00. Causal relationship: Yes. On an unspecified date the patient experienced with second covid vaccination, temperature rose to 100.2. On an unspecified date the patient underwent lab tests and procedures which included body temperature: 100.2 Temperature rose to 100.2. Patient did not require treatment. Adverse event did not require a visit to emergency room, physician office. Outcome of the event was resolved on an unspecified date. Information regarding lot/batch number has been requested. Follow-up (13May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647991
Sex: F
Age:
State: OR

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Diarrhea (gone to bathroom roughly 8 times today. Intense cramping along with it); Diarrhea (gone to bathroom roughly 8 times today. Intense cramping along with it); light headed; overall feeling unwell; This is a spontaneous report from a contactable other health care professional (patient). A 31-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EN6201, patient was 31-year-old and not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 16Feb2021 at 07:30 PM as DOSE 2, SINGLE for covid-19 immunisation. Medical history reported as no. Concomitant medication(s) included amlodipine (AMLODIPINE); methylphenidate (METHYLPHENIDATE); omeprazole (OMEPRAZOLE) all taken within 2 weeks of vaccination. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL3246, patient was 31-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 16Jan2021 as DOSE 1, SINGLE for covid-19 immunisation. No other vaccine received in four weeks. No Covid prior vaccination, not tested covid post vaccination. No Known allergies reported. On 17Feb2021, the patient experienced diarrhea (gone to bathroom roughly 8 times today. intense cramping along with it), lightheaded, overall feeling unwell. No treatments were received for events. The outcomes of events were not recovered. Follow-up (13May2021): Follow-up attempts completed. No further information expected.

Other Meds: AMLODIPINE; METHYLPHENIDATE; OMEPRAZOLE

Current Illness:

ID: 1647992
Sex: U
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Hip flexor pain; This is a spontaneous report from a contactable physician. This Physician reported similar events for three patients. This report is for 2nd of three patient. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a Dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Facility of the most recent COVID-19 vaccine was administered was reported Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The reporter was EM physician and mentioned that, approximately 5 days after vaccination reporter got hip flexor pain. The reporter stated that, the reporter knew 2 others with similar experience and reporter advised them to contact Pfizer also. The reporter stated that keep up the good work! Thanked Pfizer for all that you did. The outcome of the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647993
Sex: U
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: hip flexor pain; This is a spontaneous report from a contactable physician. This physician reported similar events for three patients. This report is for 3rd of three patients. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that, approximately 5 days after vaccine, the patient started to get hip flexor pain on an unspecified date. Stated that, the reporter was an EM physician and the reporter know 2 others with similar experiences and advised them to contact Pfizer also. The outcome of the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1647994
Sex: M
Age:
State: NY

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: the arm on the intake side felt heavy and dull pain; the arm on the intake side felt heavy and dull pain; swelling in my arms; This is a spontaneous report from a contactable physician (patient), mail trail received in response to the query sent regarding the translation of language. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 10Feb2021 as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The 1st dose of COVID-19 vaccine (COMIRNATY) was inoculated at noon on 10Feb2021, immediately felt swelling in arms and after 4 hours later, the patient felt mild heavy sensation and dull pain in the vaccinated arm. Now, the patient had recovered and had no problem. A doctor who was personal in "PRIVACY" went to the United States to study abroad at "PRIVACY" the other day. At the university, the patient received the community as a preliminary intake for medical staff. The patient received a comment in a chat online with the intention of giving an impression after ingestion. The patient was reconfirmed the date of occurrence of the event with the reporter's doctor. The outcome of the events was reported as resolved on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1647995
Sex: F
Age:
State: MA

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210218; Test Name: mild fever; Result Unstructured Data: Test Result:99.5 degrees

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: radiating myalgia; right arm muscle soreness; pain; minor headache; fatigue; chills; night sweats; mild fever; This is a spontaneous report received from a contactable consumer or other non hcp.A 31-years-old female patient received 2nd dose of bnt162b2 (Pfizer-covid19 vaccine,Batch/Lot Number: EL3247; Expiration Date: May2021),via an unspecified route of administration, administered in Arm Left on 17Feb2021 21:15,at the age of 31 years old, as Dose 2,single for covid-19 immunization.The patient medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported.The patient experienced radiating myalgia, right arm muscle soreness, pain, minor headache , fatigue, chills, night sweats, mild fever on 18Feb2021 12:00 with outcome of recovering.The patient underwent lab tests and procedures which included pyrexia: 99.5 degrees on 18Feb2021.The patient previously received her 1st dose of Pfizer covid19 vaccine on 26 jan2021,02:00 am.The patient had not been diagnosed with covid19 vaccine prior to vaccination and not tested for covid19 post vaccination.The patient had not received any treatment for the event.The outcome of the event was recovering. Follow-up (14MAY2021): Follow-up attempts completed. No further information expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1647996
Sex: F
Age:
State: CT

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210217; Test Name: slight fever; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Body aches and pains; tightness of chest; a slight mental fog; headache; slight fever; chills; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 17Feb2021 at 13:15 (at the age of 24-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications in two weeks included ethinylestradiol, levonorgestrel (LEVONORGESTREL AND ETHINYL ESTRADIOL), taken for birth control. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 27Jan2021 at 13:15 (at the age of 24-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. No COVID prior vaccination and no COVID tested post vaccination. On 17Feb2021 at 21:00, around 8 hours after injection, the patient experienced body aches and pains developed along with chills, tightness of chest, a slight mental fog, headache and a slight fever. The reporter considered the events as non-serious. Treatment was not received for the events. On 17Feb2021, the patient underwent lab tests and procedures which included slight fever (body temperature), resulted as unknown results. The outcome of the events was recovered on an unspecified date in 2021. Follow-up attempts completed. No further information expected.

Other Meds: LEVONORGESTREL AND ETHINYL ESTRADIOL

Current Illness:

ID: 1647997
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: got colds after the first dose; This is a spontaneous report from a non-contactable consumer (patient) from a Pfizer sponsored program COVAX US Support. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced colds after the first dose on an unspecified date. The patient took Tylenol and Acalka Ferrer for his colds. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1647998
Sex: F
Age:
State: AL

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Very slight chills lasting 2 hours evening after first dose.; Slightly sore arm; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 71-years-old non-pregnant female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Left arm on 28Jan2021 at 01:00 pm (71-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. Medical history included hbp (high blood pressure), high cholesterol, hypothyroid from an unknown date and unknown if ongoing. The patient have allergies to bees and sulfa. Concomitant medications included Levothyroxine (LEVOTHYROXINE SODIUM), Sanctura (TROSPIUM CHLORIDE), Pravastatin (PRAVASTATIN), Buspar (BUSPIRONE HYDROCHLORIDE), Ateno (ATENOLOL); all for unknown indications from unknown dates and unknown if ongoing. The patient previously took tramadol (TRAMADOL), celebrex (CELEBREX) and theophylline (THEOPHYLLINE) and experienced allergies. The patient had not received any vaccine within four weeks. The patient had no covid prior to vaccination. The patient was not tested since vaccination. On 28Jan2021, at 08:00 pm, the patient experienced very slight chills in the evening after first dose and slightly sore arm at. No treatment was received for the events. The outcome of the events were recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: LEVOTHYROXINE SODIUM; SANCTURA; PRAVASTATIN; BUSPAR; ATENO

Current Illness:

ID: 1647999
Sex: F
Age:
State: OH

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: rashes face, back, and chest.; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 11Feb2021 at 12:00 PM as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 11Feb2021 at 12:00 PM the patient experienced rashes face, back, and chest. The clinical outcome of the event was unknown. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648000
Sex: F
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: a little soreness in our arms.; This is a spontaneous report from a contactable Consumer, the patient. A 77-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on an unspecified date in 2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a little soreness in our arms on an unspecified date. Caller stated that she and husband had Pfizer vaccine two weeks ago. Stated that their arm was a little sore at first with no other symptoms. Wanted to know if one can get side effects after two weeks. Clarified that it was the right arm. Clarified that it is for Pfizer Covid vaccine. Outcome of the event was unknown. Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648001
Sex: M
Age:
State: NJ

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210217; Test Name: fever; Result Unstructured Data: Test Result:high

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Started having chills at night; could not sleep; Then had a high fever; Back ache; pain in the arm; This is a spontaneous report from a contactable consumer. A 36-year old male received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was EL9266) via an unspecified route of administration, in left arm on 17Feb2021 (age at the time of vaccination was 36-year-old) at 8:00, as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was EL9264) via unspecified route in left arm on 27Jan2021 (age at the time of vaccination was 36-year-old) at 17:00 as a single dose for COVID-19 immunization. The patient did not have COVID prior to vaccination and was not tested for COVID post vaccination. On 17Feb2021, at 22:00, the patient experienced, Started having chills at night and could not sleep, Then had a high fever, back ache and pain in the arm by vaccine site. Outcome of all the events was recovering. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648002
Sex: F
Age:
State: IL

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: headache; This is a spontaneous report from a contactable consumer or other non hcp (patient) from a Pfizer sponsored program COVAX Support. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on 11Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 11Feb2021, the patient experienced headache. Verbatim and Event Description: Patient received the first dose of Covid-19 vaccine today, 5-6 hours ago and she is experiencing headache. Asking if she can take Tylenol for the headache. Outcome of the event was unknown. Follow-Up (PRD/SRD 02Apr2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648003
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: fever; This is a spontaneous report received from a contactable consumer (Patient) via Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever. The outcome of event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648004
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: body aches after taking the first dose; had fever; This is a spontaneous report received from a non-contactable consumer or other non hcp. A patient of unspecified age and gender received 1st dose of bnt162b2 (Pfizer's COVID-19 vaccine,Batch/Lot Number: EL9269), via an unspecified route of administration on an unspecified date as Dose 1,single for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced body aches after taking the first dose and had fever on an unspecified date. No follow-up attempts are possible. No further Information is expected.

Other Meds:

Current Illness:

ID: 1648005
Sex: M
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: She said her husband had experienced Fever; Chills; Diarrhea; This is a spontaneous report from a sponsored program Support. A contactable consumer (wife) reported for a male patient (husband). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The caller was calling on behalf of her husband. She said her husband had experienced fever, chills and diarrhea on an unspecified date, after receiving the first shot of Covid-19 Vaccine. She was asking 2 weeks after receiving the first shot side effects occur. The outcome of the events was unknown. Follow-up attempts completed. No further information expected. Information about lot/batch number requested. Follow-up (11May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648006
Sex: M
Age:
State: MA

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Severe headache; fever; tiredness; This is a spontaneous report from a contactable other health care professional (reported for himself). A 38-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL3247/Batch number was not reported), dose 2 intramuscular, administered in arm right on 16Feb2021 at 15:00 (at the age of 38-years-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 intramuscular, administered in arm right on 28Jan2021 at 15:00 (at the age of 38-years-old) as dose 1, single for covid-19 immunisation. On 17Feb2021 at 07:00, the patient experienced severe headache, fever and tiredness. No treatment was given for the events. The outcome of the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648007
Sex: F
Age:
State: MA

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: a small nosebleed; Felt very fatigued for the following 2 days(stayed home); experienced mild nausea; dizziness; This is a spontaneous report from a contactable other healthcare professional (Patient). A 27-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, on 16Feb2021 at 10:00 (at the age of 27-year-old), as dose 2, single in left arm for COVID-19 immunization at Workplace clinic. The patient's medical history was not reported. Patient had no known allergies. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, on 25Jan2021 at 11:15 AM (at the age of 27-year-old), as single dose in left arm for COVID-19 immunization. Concomitant medications in two weeks were reported as daily multivitamin, ibuprofen; taken for unspecified indications, start and stop dates were not reported. Patient did not receive any other vaccine in four weeks after COVID vaccination. On 16Feb2021 at 12:00 PM, 2 hours after second dose of vaccine, the patient felt very fatigued for the following 2 days (stayed home), experienced mild nausea and dizziness. On 17Feb2021 morning, on second day after dose 2, the patient experienced a small nosebleed. Patient still felt fatigued on day 3, although much better. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of all the events was recovering. Follow-up attempts completed. No further information expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1648008
Sex: F
Age:
State: MN

Vax Date: 02/08/2021
Onset Date: 02/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: She developed a dry, itchy rash on her shins; She developed a dry, itchy rash on her shins; This is a spontaneous report from a contactable other hcp. A 77-year-old female non pregnant patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 intramuscular on 08Feb2021 (at the age of 77-year-old) (Batch/Lot Number: EN5318) as dose 1, single for covid-19 immunisation. Medical history arthritis and hyperlipidemia from an unknown date and unknown if ongoing. The patient previously experienced known allergies: Iodine Dye. The patient's concomitant medications were not reported. The patient experienced a dry, itchy rash on her skin 4 days after the vaccination (12Feb2021). She think it was because it had been cold and dry out, but she was remarkably insistent that it was a vaccine effect. The patient received treatment for the events. The treatment medication was topical steroids. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination. The outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648009
Sex: F
Age:
State: FL

Vax Date: 01/25/2021
Onset Date: 02/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210216; Test Name: body temperature; Result Unstructured Data: Test Result:101 Fahrenheit; Test Date: 20210218; Test Name: body temperature; Result Unstructured Data: Test Result:99 Fahrenheit

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: experience felt like the flu; Slight headache; low grade fever; chills; She reports a fever of 101?F; feeling achy all over; This is a spontaneous report from a contactable consumer or other non-Hcp. A 80-years-old female patient received first dose of bnt162b2 (BNT162B2, Formulation; Solution for injection, Lot Number: EL9263 Expiry date: Unknown) via an unspecified route of administration, administered in Deltoid Left on 25Jan2021 at 13:15 as dose 1, single for COVID-19 immunisation. The patient medical history included bronchitis from an unknown date and unknown if ongoing She reported a long time ago, she would get Bronchitis, but not for a long time now. The patient's concomitant medications were not reported. On 16Feb2021 at 00:15 the patient experienced a fever of 101?f, feeling achy all over, chills, on 18Feb2021 patient experienced low grade fever, experience felt like the flu, slight headache, The patient underwent lab tests and procedures which included body temperature: 101 Fahrenheit on 16Feb2021, body temperature was 99 Fahrenheit on 18Feb2021. The outcome of events pain, influenza like illness and chills was unknown, outcome of pyrexia was not recovered. Patient's Medical History (including any illness at time of vaccination) Provide other relevant medical history including but not limited to these conditions: diagnosed allergies, compromised immune status, respiratory illness, genetic / chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity: None. She reported a long time ago she would get Bronchitis, but not for a long time now. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1648010
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Caller's daughter had her appointment for the second dose of the Pfizer covid vaccine cancelled twice and it has almost been a month and a half since her first dose.; Caller's daughter had her appointment for the second dose of the Pfizer covid vaccine cancelled twice and it has almost been a month and a half since her first dose.; flushing; This is a spontaneous report from a contactable consumer. A female patient (consumer's daughter) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified age, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Caller's daughter had her appointment for the second dose of the Pfizer covid vaccine cancelled twice and it has almost been a month and a half since her first dose. Caller wanted to know how long the second dose of the vaccine may be given for it to be considered effective and asked do you have any information on the effectiveness of the vaccine if only one dose was received. Caller mentioned that she experienced some flushing after receiving the first dose on an unspecified date and wanted to know if this has been reported prior. She stated that this has been the third person she was transferred to, potential duplicate AE report filed and asked was it okay to get the vaccine if you have a cold. Outcome of the events was unknown. Information about lot/Batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648011
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: had headache for 2 hrs; This is a spontaneous report from a contactable Consumer. This 59-Year-old male Consumer reported in response to Non-HCP letter sent in a cross-reference case which included that: A 59-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 59-year-old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 3Dec2020 as single dose for covid-19 immunisation and experienced the events Feeling tired, Headache, Nauseous and had the chill. Patient reported that I was feeling tired & had the chill for three after first shot. Second shot had headache for 2 hrs. The outcome of the event was reported as recovered on an unspecified date. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648012
Sex: M
Age:
State:

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Swelling under left armpit; Tenderness; This is a spontaneous report from a non-contactable consumer (patient). A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3247) via an unspecified route, administered in Left Arm on 16Feb2021 at 13:15 (44-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Facility type vaccine was reported as Workplace clinic. The patient had not received any other vaccine within 4 weeks prior to vaccination. The patient was not diagnosed with Covid prior vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3247) via an unspecified route, administered in Left Arm on 26Jan2021 at 13:00 (44-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. On 17Feb2021 at 17:00, the patient had experienced Swelling under left armpit with some tenderness. The patient was not tested for Covid post vaccination. No treatment received for resulted events. The outcome of the events was recovering. No follow-up attempts are possible. No further information was expected.

Other Meds:

Current Illness:

ID: 1648013
Sex: F
Age:
State:

Vax Date: 02/16/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: This is a spontaneous report from a contactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# and expiration date: not reported), via an unspecified route of administration, on Feb 16, 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. The caller stated she received her first COVID-19 vaccine from Pfizer and did not have allergic reaction the first 15 minutes afterwards. However, after 24 hours, on an unspecified date, patient experienced swelling of tongue and face and had bumps on chin, with outcome of unknown. She asked whether she could take the second dose of the Moderna vaccine. Information on the batch/lot number requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648014
Sex: M
Age:
State: MI

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Flu-like symptoms; Chills; mild fever; achy joints; This is a spontaneous report from a contactable consumer (Patient). A 51-years-old male patient received BNT162B2 (COMIRNATY; Formulation: Solution for injection, Batch/Lot Number: EL3248), via an unspecified route of administration, administered in Arm Left on 12Feb2021 08:00 (at the age of 51-years-old) as dose 2, single for COVID-19 immunization. Medical history was reported as none. No other vaccine was given in four weeks. No known allergies were reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. Historical vaccine included BNT162B2 (COMIRNATY, solution for injection, Batch/Lot Number: EL3248), via an unspecified route of administration, administered in arm left on 22Jan2021 08:00 (at the age of 51-years-old) as single for COVID-19 immunization. There were no concomitant medications was given in two weeks. On 13Feb2021 02:00 the patient experienced flu-like symptoms, chills, mild fever and achy joints. Patient did not receive any treatment for events. The outcome of the events was recovered on an unspecified date and month of 2021. Follow-up (25Feb2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the confirmation for Pfizer receipt date. Response received and awareness date was confirmed as 13Feb2021 the day after the vaccine was administered. Follow-up (11May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648015
Sex: F
Age:
State: TX

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210212; Test Name: body temperature; Result Unstructured Data: Test Result:Fever

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Eye and face twitching on left side of face occurred 6 days after the vaccine; Severe pain and swelling in lymph nodes; Severe pain and swelling in lymph nodes; Limited mobility of left arm that lasted for more than 5 days; Tenderness still occurs; Friday night to Saturday with chills; fever; muscle ache; slept for almost 19 hours straight; This is a spontaneous report from a contactable other health care professional (patient). A 47-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 12Feb2021 at 10:30 hours (Batch/Lot Number: EN5318; Expiration Date: May2021) as DOSE 2, SINGLE (at the age of 47-years-old) for COVID-19 immunisation. The patient's medical history included migraine from an unknown date and unknown if ongoing. The patient had known allergies with penicillins, sulfa drugs, doxycycline, tetracycline, cephalosporins, latex, adhesive, and iodine from an unknown date and unknown if ongoing. Concomitant medications included naproxen sodium; and fexofenadine hydrochloride, pseudoephedrine hydrochloride (ALLEGRA D). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 22Jan2021 at 09:45 AM (Batch/Lot Number: EL3248; Expiration Date: 30Apr2021) as DOSE 1, SINGLE for COVID-19 immunisation. On 12Feb2021 at 11:30, the patient experienced severe pain and swelling in lymph nodes in left armpit within 1 hour of receiving the vaccine, limited mobility of left arm that lasted for more than 5 days, tenderness still occurs, slept for almost 19 hours straight Friday night to Saturday with chills, fever and muscle ache. On 18Feb2021, the patient experienced eye and face twitching on left side of face, occurred 6 days after the vaccine. The patient underwent lab tests and procedures which included body temperature: fever on 12Feb2021. The patient did not receive treatment for the adverse events. The patient did not have COVID prior vaccination and did not get COVID tested post vaccination. The patient did not have any other vaccine in four weeks. The patient was recovering from the adverse events. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds: NAPROXEN SODIUM; ALLEGRA D

Current Illness:

ID: 1648016
Sex: F
Age:
State:

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: intense nerve pain; Headache; Chills; joint pain; This is a spontaneous report from a non-contactable other hcp (Patient). A 18-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EL9264) via an unspecified route of administration (Age at vaccination 18-year) in Left Arm on 16Feb2021 at 01:30 PM as dose 2, single for COVID-19 immunization. Medical history included Walnuts allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 (lot number: EL9261) administered in left arm as single dose on 26Jan2021 at 01:00 PM for COVID-19 immunization. The patient received no other vaccine in four weeks. No COVID prior vaccination was reported. The patient not tested COVID post vaccination. On 16Feb2021 at 02:00 AM the patient experienced intense nerve pain, headache, chills, joint pain. It was reported by the patient that "she experienced intense nerve pain and joint pain all over her body. This lasted approximately 18 hours. She did not have a fever. She also experienced a constant headache and chills." The patient received no treatment for the adverse events. The clinical outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1648017
Sex: F
Age:
State: VA

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: chest pain; dizziness; joint and muscle pain; joint and muscle pain; severe headache & tinitius; severe headache & tinitius; EXTREME FACIAL SWELLING; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, solution for injection, Lot number: EN6200), via an unspecified route of administration, in Arm Right on 13Feb2021 09:30 (age at the vaccination 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included allergies to medications, mild arthritis, allergy; tree Nuts, Mango, Shrimp, allergy: cats. Concomitant medications included cyanocobalamin (B12), ascorbic acid (C), celecoxib (CELEBREX) taken for adenomatous polyposis coli, colecalciferol (D3), estrogens conjugated (PREMARIN) and levothyroxine sodium (LEVOTHYROXINE). The patient previously took penicillin [benzylpenicillin] and experienced allergies. The patient historical vaccine includes first dose of COVID vaccine (COMIRNATY, solution for injection, Lot number: EN9262) on 23Jan2021 09:30 AM in right arm for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. After second dose patient experienced chest pain on 14Feb2021 04:30 AM, and dizziness, joint pain, muscle pain, severe headache, tinitius, and extreme facial swelling on an unspecified date in 2021. Therapeutic measures were taken as a result for all events. The outcome of the events was recovering. Follow-up (31May2021): Follow-up attempts completed. No further information expected.

Other Meds: B12 [CYANOCOBALAMIN]; C [ASCORBIC ACID]; CELEBREX; D3; PREMARIN; LEVOTHYROXINE [LEVOTHYROXINE SODIUM]

Current Illness:

ID: 1648018
Sex: F
Age:
State: CO

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210209; Test Name: CBC; Result Unstructured Data: Test Result:unknown result; Test Date: 20210209; Test Name: CMP; Result Unstructured Data: Test Result:unknown result; Test Date: 20210209; Test Name: covid antibodies; Result Unstructured Data: Test Result:unknown result; Test Date: 20210209; Test Name: covid test; Result Unstructured Data: Test Result:unknown result; Test Date: 20210209; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: heart burn; This is a spontaneous report from a contactable nurse (patient). A 29-years-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration date was unknown), via intramuscular in arm right on 18Dec2020 at 10:30 AM (at the age of 29-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history was not reported. The patient with known allergies were reported as none. The patient's concomitant medications included metformin, levothyroxine sodium, loratadine (CLARITIN [LORATADINE]), all were taken for an unspecified indication. It was reported that, the patient was not pregnant at time of vaccination. No covid prior vaccination and covid tested post vaccination was reported as yes. On an unspecified date, at 2 weeks post first vaccine, the patient experienced heart burn for about a week, not a huge deal. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the event included was the patient went to her PCP where additional labs were drawn CBC, CMP, covid antibodies and covid test. On 09Feb2021, the patient underwent lab tests and procedures which included CBC, CMP, covid antibodies, covid test, all were resulted as unknown result and nasal swab, resulted as negative. The outcome of the event was recovering. Follow-up attempts completed. No further information expected.

Other Meds: METFORMIN; LEVOTHYROXINE SODIUM; CLARITIN [LORATADINE]

Current Illness:

ID: 1648019
Sex: F
Age:
State: CA

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:99.0-101.6; Test Date: 20210108; Test Name: Fever; Result Unstructured Data: Test Result:fever over 100.3

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Injection site pain; leg muscle soreness; This is a spontaneous report from a contactable Other-HCP. A 41-years-old female patient received first dose of bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot number Ek5730), via an intramuscular route of administration on 18Dec2020 at 07:35(at the age of 41-years-old) into Arm Left as a single dose for COVID-19 immunisation at hospital. Medical history included asthma from 09Jan1981 and ongoing, polycystic ovaries from 15Aug2016 and ongoing, Allergies from an unknown date and unknown if ongoing, High Blood pressure from an unknown date and unknown if ongoing. Concomitant medication(s) included mometasone furoate (MOMETASONE FUROATE) taken for Allergies from 15Jul2010 to an unspecified stop date; cetirizine hydrochloride taken for Allergies from 30Aug2013 to an unspecified stop date; lisinopril taken for High Blood pressure from 15Jul2016 to an unspecified stop date. On an unspecified date, the patient experienced Injection site pain,8-10 hours after injection leg muscle soreness. Treatment included Magnesium 400mg, Electrolyte water, Ibuprofen for the events. No culture was performed. The events did not require visits to the emergency room or the physician's office. The patient received acetaminophen 400 mg (2x200 mg) by mouth on 08Jan2021 for fever,30 hours after injection fever over 100.3. The patient underwent lab tests and procedures which included body temperature: 99.0-101.6 on an unknown date, body temperature: fever over 100.3 on 08Jan2021.The outcome of the events was recovered. Follow-up (11May2021): Follow-up attempts completed. No further information expected.

Other Meds: FLONASE [MOMETASONE FUROATE]; CETIRIZINE HYDROCHLORIDE; LISINOPRIL

Current Illness: Asthma; Polycystic ovarian syndrome

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am